Vaccina-tion against Lyme disease with recombi-nant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant
Steere AC, Sikand VK, Meurice F, Parenti DL, Fikrig E, Schoen RT, et al. Vaccina-tion against Lyme disease with recombi-nant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N Engl J Med. 1998;339:209-15. http://dx.doi.org/10.1056/NEJM199807233390401
Cultivation of Borrelia burg-dorferi from erythema migrans lesions and perilesional skin
Berger BW, Johnson RC, Kodner C, Coleman L. Cultivation of Borrelia burg-dorferi from erythema migrans lesions and perilesional skin. J Clin Microbiol. 1992;30:359-61.
Clinical characteristics and treatment outcome of early Lyme disease in pa-tients with microbiologically confirmed erythema migrans
Smith RP, Schoen RT, Rahn DW, Sikand VK, Nowakowski J, Parenti DL, et al. Clinical characteristics and treatment outcome of early Lyme disease in pa-tients with microbiologically confirmed erythema migrans. Ann Intern Med. 2002;136:421-8.
Direct molecular detection and geno-typing of Borrelia burgdorferi from whole blood of patients with early Lyme disease
Eshoo MW, Crowder CC, Rebman AW, Rounds MA, Matthews HE, Picuri JM, et al. Direct molecular detection and geno-typing of Borrelia burgdorferi from whole blood of patients with early Lyme disease. PLoS ONE. 2012;7:e36825. http://dx.doi.org/10.1371/journal.pone.0036825
Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans
Seinost G, Dykhuizen DE, Dattwyler RJ, Golde WT, Dunn JJ, Wang IN, et al. Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect Immun. 1999;67:3518-24.